Lisata Therapeutics
(NASDAQ) CLBS
Lisata Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$170.00K
Net Income (TTM)
$16.59M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CLBS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lisata Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
David J. Mazzo, PhD
Website
www.lisata.comHeadquarters
Basking Ridge, NJ 07920, US
CLBS Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-107%
Net Income Margin
-98%
Return on Equity
-84%
Return on Capital
-1%
Return on Assets
-93%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$15.95M
Capital Expenditure
$28.00K
Free Cash Flow
$15.98M
Cash & ST Invst.
$15.96M
Total Debt
$0.00
Lisata Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$100.00K
+100.1%
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
27
N/A
Net Income
$2.95M
-26.3%
EBITDA
$4.21M
+292.2%
Quarterly Fundamentals
Net Cash
$15.96M
-48.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-93.47%
N/A
Return on Invested Capital
-1.24%
N/A
Free Cash Flow
$3.25M
+13.4%
Operating Cash Flow
$3.25M
+19.7%